DocMorris AG (XSWX:DOCM)

Full Year 2025 DocMorris AG Earnings Call Transcript

Mar 19, 2026 / 10:00 AM GMT

Release Date Price: CHF4.01 (-2.57%)

Transcript

Key Points

Positve

DocMorris AG (XSWX:DOCM) achieved a revenue growth of 11.1% and met its financial targets for 2025.
The company's digital services segment experienced a remarkable growth rate of 110%, contributing significantly to profitability.
The AI Health Companion, launched as a beta version, has been rapidly adopted, with every third app user utilizing the assistant.
DocMorris AG (XSWX:DOCM) maintains a strong liquidity position with CHF160 million, providing confidence for future execution.
The company has formed a strategic partnership with Google to leverage AI capabilities, enhancing its digital healthcare platform.

Negative

The segment EU showed modest growth and remains slightly EBITDA negative due to low growth and indirect cost base.
Distribution expenses increased due to higher logistics and transport costs, impacting overall profitability.
The net financial result showed a negative impact of 12 million, primarily due to non-cash effects related to intercompany loans.
The company faces challenges in achieving EBITDA break-even in 2026 and free cash flow break-even in 2027.
There is uncertainty in the RX growth outlook, which is a primary swing factor in the company's guidance range.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

DOCM.S - DocMorris AG
Full Year 2025 DocMorris AG Earnings Call
Mar 19, 2026 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
So good morning everybody here in Zurich and at the webcast. It is a pleasure for us to present our full year result 2025. With me today is Daniel West, our CFO. My name is Walter Hess. I am the CEO.

Let's go straight.

To the highlights of 2025.

We delivered on our promises and we met the financial targets 2025.

We achieved 11.1.

11.1% of revenue growth and 48% of just GPTA and with that we achieved our guidance.

The growth of RX was 33.2% and of non-Rx 7.1%. The digital services With a growth of 110%, so a remarkable growth rate again.

And a significant profitability contribution.

It's a contribution margin 3, which is more than 50% already of the total company.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.